Tatiana Yu. Batenkova

Laboratory Resistance to Antiplatelet Therapy as Part of Secondary Prevention of Ischemic Stroke in a Young Patient (Clinical Case)

Tatiana Yu. Batenkova, Л. И. Волкова

In recent years, the incidence of ischemic strokes in young people worldwide has been increasing, leading to early disability, loss of work capacity, and reduced quality of life. Platelets play an active role in the pathogenesis of ischemic stroke. The main drugs …

ru (code pays fourni par la source)

Clinical and genetic risk factors for the development of laboratory resistance while taking acetylsalicylic acid in patients after atherothrombotic ischemic stroke

Tatiana Yu. Batenkova, Л. И. Волкова, Elena Partynova

ru (code pays fourni par la source)

Laboratory Resistance to Antiplatelet Therapy as Part of Secondary Prevention After Atherothrombotic Stroke in the Early Recovery Period (On the Example of Clinical Cases)

Tatiana Yu. Batenkova

Introduction. Atherosclerosis of a major cerebral artery is the main cause of atherothrombotic ischemic stroke. Platelets are actively involved in the pathogenesis of the formation and progression of an atherosclerotic plaque. Acetylsalicylic acid (ASA) is the main drug for secondary prevention of …

ru (code pays fourni par la source)

Clinical and Genetic Characteristics of Antiplatelet Therapy Resistance After Ischemic Stroke (Literature Review)

Tatiana Yu. Batenkova, Л. И. Волкова, Е. V. Kudryavtseva

Every year, 20 % of all ischemic strokes are recurrent, characterized by severe course and high mortality and disability rates. Secondary prevention measures are aimed at preventing repeated brain catastrophes, which leads to a 20–30 % reduction in the risk of recurrent …

ru, bd (code pays fourni par la source)

Cerebral vein thrombosis: from risk factors to recanalization and clinical outcomes. A review

Tatiana Yu. Batenkova

Cerebral vein thrombosis or cerebral venous thrombosis (CVT) is a complex venous thromboembolic disease with a different clinical picture, etiology and multiple potential complications. The frequency of occurrence is 0.5–1% of all stroke cases. Clinical symptoms occur as a result of increased …

ru (code pays fourni par la source)

Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19

Adrian Scutelnic, Anita van de Munckhof, Angel Miraclin T, Sanjith Aaron et autres

Abstract Introduction: Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019 associated cerebral venous thrombosis (COVID-CVT). We assessed the clinical characteristics and outcomes in an international cohort of …

ch, nl, in, pk, md, se, it, gr, us, es, ie, fr, de, ru, be, no, pt, fi (code pays fourni par la source)

Pudendal neuropathia. A case report

Tatiana Yu. Batenkova

Pudendal neuropathia is a rare disease caused by entrapment or compression of the pudendal nerve in various anatomical structures. Pudendal neuropathia impacts the quality of patients’ life significantly, and restricts the activities of daily living dramatically. The diagnosis of pudendal neuropathia is …

ru (code pays fourni par la source)